Healthcare workers are more likely than non-healthcare workers to report a diagnosis of anxiety and depression, but these conditions often remain untreated.

Semaglutide and tirzepatide use is rising among patients with rheumatic and musculoskeletal diseases and is linked to meaningful 1-year weight loss, especially in tirzepatide users.

Pierre de Brémond d’Ars, a French GP who leads the evidence-based medicine group NoFakeMed, tells Medscape’s French edition ...

Participants on weekly injections of 12 mg retatrutide lost an average of 70.3 lbs (28.3%) over 80 weeks, and 45.3% of participants achieved ≥ 30% weight loss.

Over half of patients in a randomized trial switch from enzalutamide to darolutamide because of cognitive issues; no one switches in the opposite direction.

A new study finds that prior authorization requirements vary widely across major insurers and suggests large language models ...

Analysis of data from the PUSH randomized trial affirmed that more fluid increase is better, but some still helps.

Biopsy and next-generation sequencing identified an HSV 1 variant causing ulcerative esophagitis and ileitis in a healthy 26 ...

An analysis conducted in an integrated healthcare system provided insights into the long-term healthcare burden of cCMV ...

One fifth of pregnant women are not being screened in a timely manner for syphilis, according to a new study in Ontario.

Creatinine muscle index can serve as a blood biomarker to estimate low muscle mass and identify individuals at an increased ...

The FDA’s recent approval of baxdrostat may usher in new possibilities for treatment for uncontrolled hypertension.